Decent Holding Inc. Announces Closing of $1.23 Million Follow-on Offering

The financing includes warrants to purchase up to 822,828 additional Class A ordinary shares at $1.50 per share.

Rhea-AI Summary

Decent Holding (NASDAQ: DXST) closed a follow-on offering to an institutional investor, raising approximately $1.23 million in gross proceeds.

The registered direct offering covered 822,828 Class A ordinary shares, or pre-funded warrants in their place, at a purchase price of $1.50 per share. A concurrent private placement issued unregistered warrants to purchase up to 822,828 Class A ordinary shares at an exercise price of $1.50 per share. Gross proceeds exclude placement agent fees and other offering expenses. The company intends to use net proceeds for working capital and general corporate purposes. FT Global Capital acted as exclusive placement agent.

1 point · 1 major

MixediHow this balance works

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

How the balance worksHow Sentiment works

1 major · 3 points

Hollow bars mark forward-looking points. How the balance works

Positive

• Major pointCompleted offering raised approximately $1.23 million in gross proceeds from an institutional investor. 23% of market cap

Negative

• Major point822,828 Class A ordinary shares, or pre-funded warrants instead, at $1.50 per share dilute existing holders.
• Minor point. Forward-looking: it has not happened yet and may not happen.Unregistered warrants permit purchases of up to 822,828 shares at $1.50 per share, creating potential additional dilution.
• Minor pointPlacement agent fees and other offering expenses reduce the approximately $1.23 million gross proceeds.

Argus 15 min delay 34 alerts

+31.61% vs previous close $2.79 last price 23.3x rel. volume Open Argus

Details

Market Reaction – DXST

+44.8% Peak in 1 min

$2.09 – $3.20 Day Range

$6.18M Market Cap

On Oct 5, the day this news came out, the latest delayed price for DXST is 31.61% above the previous close. Argus tracked a peak move of +44.8% during the session. Our momentum scanner has recorded 34 alerts for this stock so far that day. The latest delayed price is $2.79. Relative volume is exceptionally heavy at 23.3x the average.

Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.

Key Figures

Gross proceeds: approximately $1.23 million Shares offered: 822,828 Class A ordinary shares Purchase price: $1.50 per share +2 more

Gross proceeds

approximately $1.23 million

Before placement agent fees and other offering expenses

Shares offered

822,828 Class A ordinary shares

Registered direct offering; pre-funded warrants could be issued in lieu

Purchase price

$1.50 per share

Registered direct offering

Warrants

Up to 822,828 Class A ordinary shares

Concurrent private placement

Warrant exercise price

$1.50 per share

Unregistered warrants

Previous Offering Reports

1 past event · Latest: Oct 02

Same Type 1 event

1. Oct 02

   Offering pricing

   24h Move

   -13.6%

   Pricing notice established the same share and warrant quantities and $1.50 terms later closed.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

registered direct offering, pre-funded warrants, shelf registration statement, prospectus supplement, +1 more

5 terms

registered direct offering financial

"in a registered direct offering, 822,828 Class A ordinary shares"

A registered direct offering is a way for a company to sell new shares of its stock directly to select investors with regulatory approval. This method allows the company to raise funds quickly and efficiently without needing a public auction, similar to offering exclusive access to a limited number of buyers. For investors, it often provides an opportunity to purchase shares at a favorable price, while giving the company immediate access to capital.

pre-funded warrants financial

"or, in lieu thereof, pre-funded warrants, at a purchase price of $1.50 per share"

Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.

shelf registration statement regulatory

"pursuant to the Company’s “shelf” registration statement on Form F-3"

A shelf registration statement is a document a company files with regulators that allows it to sell shares or bonds quickly when it’s a good time to raise money. It’s like having a pre-approved plan ready so the company can act fast without going through lengthy paperwork each time they want to sell, making fundraising more flexible.

prospectus supplement regulatory

"A prospectus supplement and the accompanying prospectus"

A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.

regulation d regulatory

"and Regulation D promulgated thereunder"

Regulation D is a set of rules that govern how companies can raise money from investors without going through the full process required for public stock offerings. It provides simplified options for private placements, making it easier for companies to seek investments from a smaller group of investors. For investors, it offers opportunities to invest in private companies, often with fewer restrictions, but also with different levels of risk and disclosure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

YANTAI, China, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Decent Holding Inc. (NASDAQ: DXST) (the “Company”), a technology-driven provider of wastewater treatment and community-based senior health and elderly care services in China, today announced the closing of its previously announced follow-on offering to an institutional investor for the sale of (i) in a registered direct offering, 822,828 Class A ordinary shares, par value of $0.0025 per share, of the Company (the “Class A Ordinary Shares”) or, in lieu thereof, pre-funded warrants, at a purchase price of $1.50 per share; and (ii) in a concurrent private placement, unregistered warrants (the “Unregistered Warrants”) to purchase up to 822,828 Class A Ordinary Shares, with an exercise price of $1.50 per share (together, the “Securities”). The offering closed on October 05, 2026. 

The gross proceeds from this offering were approximately $1.23 million, before deducting placement agent fees and other offering expenses.

The Company intends to use the net proceeds from the offering for working capital and general corporate purposes.

FT Global Capital, Inc. acted as the exclusive placement agent for the offering.

The Class A Ordinary Shares (or pre-funded warrants in lieu thereof) were offered by means of and pursuant to the Company’s “shelf” registration statement on Form F-3 (File No. 333-295313), filed with the U.S. Securities and Exchange Commission (the “SEC”) on April 24, 2026, and declared effective on May 7, 2026. A prospectus supplement and the accompanying prospectus relating to the Class A Ordinary Shares (or pre-funded warrants in lieu thereof) has been filed with the SEC and is available on the SEC’s website at www.sec.gov.

The Unregistered Warrants were issued in a concurrent private placement under Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and Regulation D promulgated thereunder and, along with the Class A ordinary shares underlying the warrants, have not been registered under the Securities Act, or applicable state securities laws. Accordingly, the warrants and underlying Class A ordinary shares may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable state securities laws.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Decent Holding Inc.

Decent Holding Inc. (NASDAQ: DXST) specializes in the provision of wastewater treatment by cleansing industrial wastewater, ecological river restoration and river ecosystem management by enhancing water quality, as well as microbial products primarily used for pollutant removal and water quality enhancement, through the Company's operating subsidiary, Shandong Dingxin Ecology Environmental Co., Ltd. In addition, through its operating subsidiary Suncare (Shanghai) Health Technology Co., Ltd., the Company operates an AI-powered, community-based senior health and elderly care platform serving China's aging population. For more information, please visit the Company’s website.

Forward-Looking Statements

This press release contains forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as “may, “will, “intend,” “plan,” “should,” “could,” “believe,” “expect,” “anticipate,” “project,” “estimate,” “potential”, or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve known and unknown risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the uncertainties related to market conditions and other factors discussed in the “Risk Factors” section of the registration statement filed with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company’s filings with the SEC, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statements to reflect subsequent events or circumstances, except as required by applicable law.

Investor Relations Contact:

WFS Investor Relations Inc.
Connie Kang, Partner
Email: ckang@wfsir.com
Tel: +86 1381 185 7742

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much did Decent Holding raise in its DXST follow-on offering?

Decent Holding raised approximately $1.23 million in gross proceeds from its completed follow-on offering to an institutional investor. That amount is before placement agent fees and other offering expenses.

What securities and prices were included in Decent Holding's follow-on offering?

The offering covered 822,828 Class A ordinary shares, or pre-funded warrants in their place, at $1.50 per share. The concurrent private placement issued unregistered warrants to purchase up to 822,828 Class A ordinary shares at an exercise price of $1.50 per share.